Featured Research

from universities, journals, and other organizations

Why Treatment Isn't Effective For HIV

Date:
August 7, 2008
Source:
University of Minnesota
Summary:
Researchers have answered a key question as to why antiretroviral therapy isn't effective in restoring immunity in HIV-infected patients. Once a person is infected with the virus, fibrosis, or scarring, occurs in the lymph nodes -- the home of T cells that fight infection. And once fibrosis occurs, T cells can't repopulate the lymph nodes when HIV therapy begins, according to a professor of medicine and principal investigator on the study.

University of Minnesota researchers have answered a key question as to why antiretroviral therapy isn't effective in restoring immunity in HIV-infected patients.

Once a person is infected with the virus, fibrosis, or scarring, occurs in the lymph nodes – the home of T cells that fight infection. And once fibrosis occurs, T cells can't repopulate the lymph nodes when HIV therapy begins, said Timothy Schacker, M.D., professor of medicine and principal investigator on the study.

"Importantly, we discovered that this fibrosis occurs more rapidly and to a greater extent in the portion of the gut – the largest lymphatic tissue in the body – containing the T cells, compared with other immune tissues," he said. "The fibrosis stops cells from returning to immune tissues, especially in the gut."

In the study, seven HIV-infected patients were treated very early after infection and experienced a greater degree of immune reconstitution than patients treated in the chronic or end stages of the disease, especially in the gut.

Schacker said it's crucial to start therapy earlier than current guidelines suggest. Beginning in the earliest stages of infection, when the patient only shows preliminarily symptoms of HIV, can preserve some elements of the immune system (mainly protecting T-cells that fight infection), he said.

The research also suggests that anti-fibrotic drugs might have a role as adjunctive therapy in HIV-1 infections – both in limiting depletion and improving reconstitution of T cells under therapy.

The results of the study, sponsored by the National Institute of Health, will be published in the Aug. 15 edition of the Journal of Infectious Disease. The article is currently online.


Story Source:

The above story is based on materials provided by University of Minnesota. Note: Materials may be edited for content and length.


Cite This Page:

University of Minnesota. "Why Treatment Isn't Effective For HIV." ScienceDaily. ScienceDaily, 7 August 2008. <www.sciencedaily.com/releases/2008/08/080805153828.htm>.
University of Minnesota. (2008, August 7). Why Treatment Isn't Effective For HIV. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2008/08/080805153828.htm
University of Minnesota. "Why Treatment Isn't Effective For HIV." ScienceDaily. www.sciencedaily.com/releases/2008/08/080805153828.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins